SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Saflink Corp. (ESAF) Biometric Software Provider -- Ignore unavailable to you. Want to Upgrade?


To: David who wrote (2256)10/29/1997 6:59:00 PM
From: brad greene  Read Replies (2) | Respond to of 4676
 
David,

It's my fault. I paved the way for you......You walked into the intensive care ward at the wrong time....as I preceded you pulling plugs and yanking IVs.

There is life here, though.......and I'm glad to see it. Sheldon and Bob are hanging tough.......But I miss Dan very much. And Jaffo seems to have laid down the sword......What gives?

Maybe the earnings release will bring this thread back to life. I want to listen to the conference call.......Hear Gustafson tell it like it is.

I'm ready to cheer.

bg



To: David who wrote (2256)10/30/1997 8:45:00 AM
From: Bob Brooke  Read Replies (2) | Respond to of 4676
 
David,

"Gamble, I think, is the best word for penny stocks."

Very good, and people gamble to make __________?

My opinion is all stocks are a gamble. The bigger the gamble, usually the bigger the payoff. Think the gamble with both NRID and IDX is will this technology be accepted outside of the government contracts that IDX has gotten. I wouldn't count the Sylvan deal, or the Columbain bank contract until they produces revenues. If biometrics doesn't take off I think both these companies are overpriced, especially NRID.
Besides David, the money I have in NRID now was all from profits I made in NRID's run up last winter. I'll concede that IDX is the better company. NRID is a better gamble.
Think what you IDX people forget about are the large companies with biometric patients, waiting until the technology gets accepted before they get into this market.

Bob